Theradaptive Receives $7.4M From DoD, Advances Human Trials With ‘Paint-Like’ Regenerative Therapeutic
Theradaptive will use the new DoD funding to move its technology for healing bones and tissues into first human trials.
Theradaptive will use the new DoD funding to move its technology for healing bones and tissues into first human trials.